Kuwait’s KSP & Abbott launch manufacturing of 26 high-quality medicines

Kuwait’s KSP & Abbott launch manufacturing of 26 high-quality medicines

Kuwait Saudi Pharmaceutical Industries (KSP) has launched the toll manufacturing of 26 high-quality medicines from the global healthcare leader, Abbott.

As per the statement, this follows the partnership agreement signed between KSP and Abbott earlier last year. The collaboration is a step toward attracting more foreign investment in the healthcare sector.

Toll manufacturing is an arrangement, where a company with specialized equipment processes raw materials or unfinished goods for a different company.

According to the reports, “This milestone marks the first time an international healthcare company such as Abbott broadens access to quality medicines by localizing their production.” The first release of the locally manufactured products is scheduled for the end of the year.

As per the statement, “By establishing reliable quality and supply of medicines in Kuwait, Abbott is delivering on its commitment to transform the way people use medicines, through differentiated products and services, which people can trust to live not just longer, but better.”

Prof. Khaled Al-Saeed

Minister of Health

Kuwait “Localizing the manufacturing of pharmaceutical products from a leading global healthcare company not only brings forward the strength of local private companies in the sector but also gives Kuwait simpler and faster access to these products. It allows the country to benefit from